Replies to post #536 on Vascular Biogenics Ltd (VBLT)

[mjw007]

Thanks for your post
I too am somewhat perplexed by the raise
Makes me question the proximity to any partnerships, etc
But we look forward to 2017
Some of these areas like NASH could turn out to be beyond great with our technology
I believe these guys are onto something big and with that I will buy you a cup up coffee as they say

Good luck to all of us patient longs
This has been a good Board to be part of as well with informative posts throughout the year

[davidal66]

Thanks for the post. The wild card of '17, non-VB-111 news event, would be a NASH deal by one of the expanding plate of NASH players.

gr, I always enjoy your thoughtful take on VBLT. david

[davidal66]

Speculation on the need for money??

1. VB601 which is not on the SNO sheet, but Dror has referred to on some prior calls, a non-angiogenic target on cancer cells....

2. Probably not this, but could they also be thinking about running a smallish phase II trial on newly diagnosed patients?